0
Inquiry Basket

There is no product in the shopping cart, buy it!

GlycoErase™ GALNT9 Knockout KD Cell Line (CAT#: GLJF-0425-JF683)

Datasheet
SizeQtyAdd To Basket
2 M cells/vial*2

Description The GALNT9 knockout KD cell line, derived from an extra-cranial rhabdoid tumor, lacks GALNT9 protein, polypeptide N-acetylgalactosaminyltransferase 9 initiating mucin-type O-glycosylation. GALNT9 knockout in rhabdoid cancer cells allows study of mucin-type O-glycosylation disruption in this pediatric sarcoma, potentially affecting Golgi glycosylation, cell surface mucins, and mucin-dependent signaling in rhabdoid tumor cells.
Product Type KO Cell Lines
Species Human
Cell Morphology Epithelial-like, adherent
Passage Ratio 1:2~1:4
Cell Line KD cell line
Primary Disease Rhabdoid cancer
Lineage Soft Tissue
Lineage Subtype Rhabdoid cancer
Cell Viability >90%
Sterility Test The sterility test indicated an absence of microbial growth.
Identity Test STR identification
Mycoplasma Test Negative
Virus Test Negative for HIV, HBV and HCV.
Genetic Stability Testing We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation PCR, Sanger Sequencing
Culture Medium F-12 & FBS & Penicillin/Streptomycin
Application Functional assay
Size 2 M cells/vial*2
Product Format Frozen
Shipping Dry ice
Availability Status Made to order
Handling Notes Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Target GALNT9
Full Name Polypeptide N-acetylgalactosaminyltransferase 9
Alternative Name GalNAc-T9
Location 12q24.33
Gene ID 50614
Summary Essential for the synthesis of mucin-type O-glycans, transferring GalNAc to target proteins and contributing to diverse cellular functions, including cell signaling and adhesion.
For Research Use Only.
Online Inquiry
Creative Biolabs-Glycoprotein Follow us on
Close
Thanksgiving
Thanksgiving